What is the debt of AstraZeneca this year?
AstraZeneca has a debt level of 22,782 USD this year.
AstraZeneca Debt 2024
AstraZeneca Debt
22,782 USD
Ticker
AZN.L
ISIN
GB0009895292
WKN
886455
In 2024, AstraZeneca's total debt was 22,782 USD, a -1.23% change from the 23,066 USD total debt recorded in the previous year.
AstraZeneca Aktienanalyse
What does AstraZeneca do?
AstraZeneca PLC is a globally operating pharmaceutical company with its headquarters in England. The company was founded in 1999 through the merger of the Swedish company Astra AB and the British Zeneca Group PLC. Today, AstraZeneca employs more than 70,000 people and operates in over 100 countries. AstraZeneca specializes in the development, manufacturing, and marketing of pharmaceutical products. The company focuses primarily on oncology, cardiovascular and metabolic diseases, respiratory diseases, and autoimmune diseases. AstraZeneca is divided into various business segments. The oncology segment is a major focus of the company. Here, medications for various types of cancer are developed and manufactured. One particularly well-known product is the breast cancer medication Tamoxifen. In the cardiovascular and metabolic diseases segment, AstraZeneca offers various medications for heart and circulatory diseases as well as diabetes. One of the most well-known medications is Crestor, which is used to lower cholesterol levels. Another important area for AstraZeneca is respiratory diseases. Medications for the treatment of asthma and chronic obstructive pulmonary disease (COPD) are developed and manufactured here. The medication Pulmicort is particularly well-known among asthma patients. Finally, AstraZeneca is also active in the field of autoimmune diseases. Medications against lupus erythematosus and rheumatoid arthritis are developed and manufactured here. AstraZeneca strives to improve healthcare worldwide through research and development of new medications. The company works closely with universities and research institutions and invests billions of dollars annually in research and development. AstraZeneca also pursues a sustainable business strategy and emphasizes acting environmentally and socially responsibly. The company is committed to reducing CO2 emissions and minimizing waste production. Over the years, AstraZeneca has received numerous awards and prizes, including the Sunday Times Innovation Award of the Decade, the Fierce Biotech Award for the medication Tagrisso, and the Prix Galien USA Award for Crestor. AstraZeneca aims to develop innovative medications that improve the lives of patients and advance healthcare worldwide. The company believes in a sustainable business strategy and actively promotes environmental and social responsibility. AstraZeneca will remain an important player in the global pharmaceutical industry in the future. AstraZeneca ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding AstraZeneca's Debt Structure
AstraZeneca's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing AstraZeneca's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to AstraZeneca’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in AstraZeneca’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about AstraZeneca Stock
What was the debt of AstraZeneca compared to the previous year?
The debt of AstraZeneca has increased by -1.23% compared to the previous year dropped.
What are the consequences of high debt for investors in AstraZeneca?
High debt can pose a risk for investors of AstraZeneca, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of AstraZeneca?
Low debt means that AstraZeneca has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from AstraZeneca affect the company?
An increase in debt of AstraZeneca can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of AstraZeneca affect the company?
A reduction in debt of AstraZeneca can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of AstraZeneca?
Some factors that can influence the debt of AstraZeneca include investments, acquisitions, operating costs, and revenue development.
Why are the debts of AstraZeneca so important for investors?
The debts of AstraZeneca are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can AstraZeneca take to change the debt?
To change the debt, AstraZeneca can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does AstraZeneca pay?
Over the past 12 months, AstraZeneca paid a dividend of 2.35 USD . This corresponds to a dividend yield of about 1.48 %. For the coming 12 months, AstraZeneca is expected to pay a dividend of 1.01 USD.
What is the dividend yield of AstraZeneca?
The current dividend yield of AstraZeneca is 1.48 %.
When does AstraZeneca pay dividends?
AstraZeneca pays a quarterly dividend. This is distributed in the months of September, March, September, March.
How secure is the dividend of AstraZeneca?
AstraZeneca paid dividends every year for the past 26 years.
What is the dividend of AstraZeneca?
For the upcoming 12 months, dividends amounting to 1.01 USD are expected. This corresponds to a dividend yield of 0.63 %.
In which sector is AstraZeneca located?
AstraZeneca is assigned to the 'Health' sector.
Wann musste ich die Aktien von AstraZeneca kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of AstraZeneca from 3/25/2024 amounting to 1.56 USD, you needed to have the stock in your portfolio before the ex-date on 2/22/2024.
When did AstraZeneca pay the last dividend?
The last dividend was paid out on 3/25/2024.
What was the dividend of AstraZeneca in the year 2023?
In the year 2023, AstraZeneca distributed 2.217 USD as dividends.
In which currency does AstraZeneca pay out the dividend?
The dividends of AstraZeneca are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The AstraZeneca stock can be added to a savings plan with the following providers: Scalable Capital and Consorsbank
Andere Kennzahlen von AstraZeneca
Our stock analysis for AstraZeneca Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AstraZeneca Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
